Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Chin Med J (Engl). 2019 May 20;132(10):1159-1165. doi: 10.1097/CM9.0000000000000238.
New definitions for sepsis and septic shock (Sepsis-3) were published, but the strategy to adjust vasopressors after the initial guidelines is still unclear. We conducted a retrospective observational study to explore dosing strategy of norepinephrine (NE).
A retrospective observational study in the 15-bed mixed intensive care unit of a tertiary care university hospital. The study was performed on septic shock patients after 30 mL/kg fluid resuscitation and mean arterial pressure (MAP) levels reached >65 mmHg requiring NE. We divided patients into NE dosage increase and decrease groups, and collected hemodynamic and tissue perfusion parameters before (T1) and after (T2) adjusting NE dosage.
In both NE increase and decrease groups, central venous pressure (CVP) and pressure difference between usual MAP and MAP (dMAP) at the T1 time point were associated with lactate clearance. In groups LC HM (CVP <10 mmHg, dMAP > 0 mmHg) and HC HM (CVP ≥ 10 mmHg, dMAP > 0 mmHg), decrease in NE dosage decreased lactate level, while in group HC LM (CVP ≥ 10 mmHg, dMAP ≤ 0 mmHg), both increase and decrease in NE dosage led to increase lactate level.
After patients with septic shock (Sepsis-3) resuscitated to reach the initial recovery target goals, combination of CVP and MAP refer to usual levels can help doctors make the next decision to make the correct choice of increase NE dosage or decrease NE dosage.
新的脓毒症和脓毒性休克定义(Sepsis-3)已经发布,但在最初的指南之后调整血管加压药的策略仍不清楚。我们进行了一项回顾性观察性研究,以探讨去甲肾上腺素(NE)的给药策略。
这是一项在三级大学附属医院的 15 张混合重症监护病房进行的回顾性观察性研究。该研究针对接受 30ml/kg 液体复苏后且平均动脉压(MAP)水平达到>65mmHg 仍需要 NE 的脓毒性休克患者进行。我们将患者分为 NE 剂量增加和减少组,并在调整 NE 剂量前后(T1 和 T2)收集血流动力学和组织灌注参数。
在 NE 剂量增加和减少组中,T1 时间点的中心静脉压(CVP)和通常 MAP 与 MAP 之间的差值(dMAP)与乳酸清除率相关。在 LC HM 组(CVP<10mmHg,dMAP>0mmHg)和 HC HM 组(CVP≥10mmHg,dMAP>0mmHg)中,降低 NE 剂量可降低乳酸水平,而在 HC LM 组(CVP≥10mmHg,dMAP≤0mmHg)中,增加和减少 NE 剂量均导致乳酸水平升高。
在复苏至初始恢复目标的脓毒性休克(Sepsis-3)患者中,CVP 和 MAP 的组合可参考常规水平,这有助于医生做出下一步决策,正确选择增加或减少 NE 剂量。